Research Article

Association between Metabolic Syndrome and Substance Dependence: A Cross-Sectional Study in Kenya

Samuel Mbugua
Mount Kenya University, Kenya
* Corresponding author
Ezekiel Mecha
University of Nairobi, Kenya
Peter Kirira
Mount Kenya University, Kenya
Margaret Njoroge
United States International University-Africa, Kenya
Boniface Malala
Mount Kenya University, Kenya
Jesse Gitaka
Mount Kenya University, Kenya
Francis Makokha
Mount Kenya University, Kenya
Catherine Mwenda
South Eastern Kenya University, Kenya
DOI icon 10.24018/ejmed.2022.4.3.1030

Read Counter
486

Downloads
303

Citations

Share

Article Sidebar

Submitted 2021-08-24
Published 2022-06-28

Read counter = 486 times

Table of Contents

Article Main Content

Metabolic syndrome and its defining components remain an understudied area of human health research in Kenya and Africa. Understanding the relationship between substance dependence and the occurrence of metabolic syndrome is critical in prevention and clinical management of the related complications. This was a cross-sectional study in 6 rehabilitative centers in 3 counties in Kenya with a conveniently selected sample size of 166 participants. A signed informed consent was obtained from each participant following which anthropometric and biochemical measurements were obtained. Descriptive statistics and chi-square test were used to describe the prevalence of metabolic syndrome and the relationship of the defining criteria with the substance of dependence. A quarter of the respondents were overweight and 6% obese. Fasting blood glucose was elevated in 62% of the sampled population with triglycerides having a significant variation with a mean of 216.95mg/ dL and a standard deviation of 151.107. A prevalence rate of 4.8% was established based on the Harmonized Joint Scientific Statement on Metabolic syndrome for the African region. 87.34% of the population showed at least one elevated defining criteria with alcohol as the most prevalent substance of dependence. There was statistical difference of fasting blood glucose and triglycerides with alcohol use. The findings indicate that alcohol use resulted to elevated levels of fasting blood glucose and triglycerides. There is need for emphasis on a multidisciplinary approach to substance dependence and metabolic syndrome management integrating physical activity interventions, dietary modifications and psychotherapeutic approaches.

Keywords: Anthropometric and biochemical measurements, metabolic syndrome, substance dependence

References

  1. Isomaa BO, Almgren P, Tuomi T, Forsén B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24(4): 683-689.
     Google Scholar
  2. Yankey BN, Strasser S Okosun IS. A cross-sectional analysis of the association between marijuana and cigarette smoking with metabolic syndrome among adults in the United States, Diabetes Metabolic Syndrome. Clinical Research Reviews. 2016; 10(2): S89-S95.
     Google Scholar
  3. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Joint scientific statement. Circulation. 2009; 120: 1640-1645.
     Google Scholar
  4. Yankey B. The connection between marijuana, cigarette smoking and metabolic syndrome among adults in the United States. 2017.
     Google Scholar
  5. World Health Organization. Targets for health for all 2000. WHO Regional Office for Europe. 1985.
     Google Scholar
  6. Johnston LD, Miech RA, O'Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Monitoring the future national survey results on drug use, 1975-2018: overview, key findings on adolescent drug use. Institute for Social Research. 2019.
     Google Scholar
  7. Sharma P, Balhara Y. Opioid use and diabetes: An overview. Journal of Social Health and Diabetes. 2016; 4(1): 6-10.
     Google Scholar
  8. Kuppili PP, Nebhinani N. Role of integrated and multidisciplinary approach in combating metabolic syndrome in patients with severe mental illness. Indian Journal of Psychological Medicine. 2019; 41(5): 466-471.
     Google Scholar
  9. Neicun J, Yang JC, Shih H, Nadella P, van Kessel R, Negri A, et al. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014. Plos One. 2020; 15(10): e024105.
     Google Scholar
  10. Mattoo SK, Chakraborty K, Basu D, Ghosh A, Vijaya KK, Kulhara P. Prevalence correlates of metabolic syndrome in alcohol opioid dependent inpatients. The Indian Journal of Medical Research. 2011; 134(3): 341.
     Google Scholar
  11. Mattoo SK, Nebhinani N, Aggarwal M, Basu D, Kulhara P. Metabolic syndrome among substance dependent men: A study from north India. Industrial Psychiatry Journal. 2013; 22(1): 60.
     Google Scholar
  12. Grover S, Aggarwal M, Dutt A, Chakrabarti S, Avasthi A, Kulhara P, et al. Prevalence of metabolic syndrome in patients with schizophrenia in India. Psychiatry Research. 2012; 200(2-3): 1035-1037.
     Google Scholar
  13. Gardner-Sood P, Lally J, Smith S, Atakan Z, Ismail K, Greenwood KE, Papanastasiou E. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychological Medicine. 2015; 45(12): 2619-2629.
     Google Scholar
  14. Walter KN, Petry NM. Patients with diabetes respond well to contingency management treatment targeting alcohol and substance use. Psychology, Health Medicine. 2015; 20(8): 916-926.
     Google Scholar
  15. Balhara YPS, Kalra S. Drug addiction and diabetes: South Asian action. The Journal of the Pakistan Medical Association. 2017; 67(6): 954-956.
     Google Scholar
  16. Djoussé L, Arnett DK, Eckfeldt JH, Province MA, Singer MR, and Ellison RC. Alcohol consumption and metabolic syndrome: does the type of beverage matter?. Obesity Research. 2004; 12(9): 1375-1385.
     Google Scholar
  17. Gigleux I, Gagnon J, St-Pierre A, Cantin B, Dagenais GR, Meyer F, et al. Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome. The Journal of Nutrition. 2006; 136(12): 3027-3032.
     Google Scholar
  18. Yoon YS, Oh SW, Baik HW, Park HS, Kim WY. Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. The American Journal of Clinical Nutrition. 2004; 80(1): 217-224.
     Google Scholar
  19. Santos AC, Ebrahim S, Barros H. Alcohol intake, smoking, sleeping hours, physical activity and the metabolic syndrome. Preventive Medicine. 2007; 44(4): 328-334.
     Google Scholar
  20. Teixeira PJR, Rocha FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Brazilian Journal of Psychiatry. 2007; 29(4): 330-336.
     Google Scholar
  21. Ojo O, Wang XH, Ojo OO, Ibe J. The effects of substance abuse on blood glucose parameters in patients with diabetes: A systematic review and meta-analysis. International Journal of Environmental Research and Public Health. 2018; 15(12): 2691.
     Google Scholar
  22. Shah K, Joshi VV, Arinze NC, Bodicherla KP, Ghimire S, Singh R, et al. Association of opioid use with cardiometabolic disease risk factors: evidence from the 2009-2018 National Health And Nutrition Examination Survey. Cureus. 2020; 12(6).
     Google Scholar
  23. Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. The American Journal of Medicine. 2013; 126(7), 583-589.
     Google Scholar
  24. Thompson CA, Hay JW. Estimating the association between metabolic risk factors and marijuana use in US adults using data from the continuous National Health and Nutrition Examination Survey. Annals of Epidemiology. 2015; 25(7): 486-491.
     Google Scholar
  25. Muniyappa R, Sable S, Ouwerkerk R, Mari A, Gharib AM, Walter M, et al. Metabolic effects of chronic cannabis smoking. Diabetes Care. 2013; 36(8): 2415-2422.
     Google Scholar
  26. Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Psychiatry. 2018; 5(12): 987-1012.
     Google Scholar
  27. Younossi ZM, Stepanova J, Ong J, Yilmaz Y, Duseja A, Eguchi Y, et al. Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease. Clinical Gastroenterology and Hepatology. 2019; 17(8), 1625-1633.
     Google Scholar
  28. Kuppili PP, Nebhinani N. Role of integrated and multidisciplinary approach in combating metabolic syndrome in patients with severe mental illness. Indian Journal of Psychological Medicine. 2019; 41(5), 466-471.
     Google Scholar